bupropion has been researched along with varenicline in 410 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 86 (20.98) | 29.6817 |
| 2010's | 250 (60.98) | 24.3611 |
| 2020's | 74 (18.05) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Caldarone, BJ; Eaton, JB; Kozikowski, AP; Lukas, RJ; Yu, LF; Zhang, HK | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Camarelles Guillem, F | 1 |
| Corelli, RL; Hudmon, KS | 1 |
| Azoulay, S; Billing, CB; Gong, J; Gonzales, D; Nides, M; Oncken, C; Reeves, KR; Rennard, SI; Watsky, EJ; Williams, KE | 1 |
| Azoulay, S; Billing, CB; Gong, J; Hays, JT; Jorenby, DE; Reeves, KR; Rigotti, NA; Watsky, EJ; Williams, KE | 1 |
| Johnson, KC; Klesges, RC; Somes, G | 1 |
| Keating, GM; Siddiqui, MA | 1 |
| Dimoulas, P; Mills, EJ; Wilson, K; Wu, P | 1 |
| Siu, EC; Tyndale, RF | 1 |
| Bullen, C; Fagerström, K; McRobbie, H; Whittaker, R | 1 |
| Frishman, WH | 1 |
| Evans, SE; Leischow, S; Nides, M; Sarna, L | 1 |
| Oberpichler-Schwenk, H | 1 |
| Martini, B | 1 |
| Bornstein, MM; Klingler, K; Ramseier, CA; Saxer, UP; Walter, C | 1 |
| Brixner, D; Dirani, R; Jackson, KC; Nahoopii, R; Said, Q | 1 |
| Vandemergel, X | 1 |
| Crane, R | 1 |
| Pipe, AL; Quinlan, B; Reid, RD; Riley, DL | 1 |
| Hering, T | 4 |
| Croghan, E | 1 |
| Coffay, AO | 1 |
| O'Brien, CP | 2 |
| Lerman, C; Patterson, F; Schnoll, RA | 1 |
| Doggrell, SA | 1 |
| Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P | 1 |
| George, TP; Le Foll, B | 1 |
| Andrews, JO; Bennett, SM; Heath, JH | 1 |
| Cahill, K; Lancaster, T; Stead, L | 2 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R | 1 |
| Cooley, ME; Murphy, M; Sarna, L; Sipples, RL | 1 |
| Bolin, K; Lindgren, B; Mörk, AC; Willers, S | 1 |
| Benowitz, NL | 2 |
| Asch, DA; Heitjan, DF; Lerman, C; Patterson, F; Ray, R; Rukstalis, M | 1 |
| Tyndale, R | 1 |
| Crawford, JT; Goldenberg, RL; Tolosa, JE | 1 |
| Baker, C; Boler, A; Howard, P; Knight, C | 1 |
| Bölcskei, PL; Walden, K | 1 |
| Tønnesen, P | 2 |
| Bélisle, P; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; Mottillo, S; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S; Yavin, D | 1 |
| Cahill, K; Lancaster, T; Stead, LF | 4 |
| Aveyard, P | 1 |
| Ferguson, SG; Shiffman, S | 1 |
| Delva, NJ | 1 |
| Bader, P; McDonald, P; Selby, P | 1 |
| Schunack, W | 1 |
| Brace, V; Danielian, P; Rore, C; Williams, D | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G | 1 |
| Rose, JE | 1 |
| Galanti, LM | 1 |
| Carrozzi, L; Pistelli, F; Viegi, G | 1 |
| Schroeder, SA | 1 |
| McEwen, A; West, R | 1 |
| Florek, E; Piekoszewski, W | 1 |
| Groman, E; Homaier, I; Lichtenschopf, A; Tschabitscher, P | 1 |
| Arora, G; Jain, M; Talwar, A | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Hurt, RD; Schroeder, DR; Sood, A | 1 |
| Ferguson, SG; Gritz, ER; Henningfield, JE; Shiffman, S | 1 |
| Silva, RR | 1 |
| Dugan, SE; Garrison, GD | 1 |
| Cryan, JF; Flynn, RA; Glynn, DA; Kennedy, MP; Kent, P | 1 |
| Laniado-Laborín, R | 2 |
| George, TP; Lising-Enriquez, K | 1 |
| Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL | 1 |
| Heimlich, L; Steinberg, ML; Williams, JM | 1 |
| Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T | 1 |
| Keiding, H | 1 |
| Elia, D; Giucastro, G; Marangio, E; Mariano, ME; Olivieri, D; Scarascia, A; Tzani, P | 1 |
| Maritz, GS | 1 |
| Kuehn, BM | 1 |
| Annemans, L; Bartsch, P; Marbaix, S; Nackaerts, K; Prignot, J | 1 |
| Kranzler, HR; Oncken, CA | 1 |
| Tonstad, S | 1 |
| Davies, C; Gunnell, D; Irvine, D; Martin, RM; Wise, L | 1 |
| Hind, D; Kenjegalieva, K; Peters, J; Tappenden, P | 1 |
| Lavigne, JE | 1 |
| Batra, A; Friederich, HM | 1 |
| Hao, W; Tan, L; Tang, Q | 1 |
| Jormanainen, V; Kotomäki, T; Linden, K; Linna, M; Sintonen, H; Wilson, K | 1 |
| Corelli, RL; Hudmon, KS; Prokhorov, AV | 1 |
| Keating, GM; Lyseng-Williamson, KA | 1 |
| Drach, L; Fox, V; Holbert, T; Maher, J; Saddler, LC; Schubert, S | 1 |
| Ainamo, A; Binnie, VI; Carr, AB; Fundak, A; Koeber, A; Koerber, A; Needleman, IG; Ohrn, K; Rosseel, J | 1 |
| Hays, JT; Lawrence, D; Lee, TC; Leischow, SJ | 1 |
| Bhat, A; Crain, D | 1 |
| Ioannides-Demos, LL; McNeil, JJ; Piccenna, L | 1 |
| Herman, AI; Sofuoglu, M | 1 |
| Ruff, P | 1 |
| Zeller, A | 1 |
| von Garnier, C | 1 |
| Arteaga, C; Brandon, TH; Gonzales, D; Jorenby, DE; Lee, TC | 1 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; Croghan, IT; Hays, JT | 1 |
| Bover, MT; Foulds, J; Richardson, DL; Schmelzer, AC; Steinberg, MB; Williams, JM | 1 |
| Johnson, TS | 1 |
| Cesario, A; Galetta, D; Granone, P; Greenberg, DS; Margaritora, S; Russo, P; Rutella, S; Spaggiari, L; Veronesi, G | 1 |
| Ebbert, JO; Hays, JT | 1 |
| Balmford, J; Borland, R; Cummings, KM; Hammond, D | 1 |
| Allan, GM; Els, C; Ivers, N | 1 |
| Weinsier, ST | 1 |
| Al Rubaiy, SA; Bloom, SA; Guendisch, D; Papke, RL; Trocmé-Thibierge, C | 1 |
| Ebbert, J; Erwin, PJ; Montori, VM; Stead, LF | 1 |
| Grief, SN | 1 |
| Díaz Cerezo, S; Martí Sánchez, B; Navarro Artieda, R; Sanz De Burgoa, V; Sicras Mainar, A | 1 |
| Coleman, T; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Croghan, IT; Ebbert, JO; Hays, JT; Schroeder, DR; Severson, HH | 1 |
| Simon, JA | 1 |
| Aubin, HJ; Karila, L; Reynaud, M | 1 |
| Fidler, JA; Kotz, D; West, R | 1 |
| Agboola, S; Coleman, T; Leonardi-Bee, J; McNeill, A; Taylor, M | 1 |
| Coleman, T; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Beebe, LA; Choi, WS; Cully, L; Daley, CM; Faseru, B; Greiner, AK; Kaur, B; Shireman, TI; Talawyma, M; Yeh, HW | 1 |
| Belcon, AL | 1 |
| Marti, J | 1 |
| Carpenter, MJ; Gray, KM; Klintworth, EM; Lewis, AL; Upadhyaya, HP | 1 |
| Barendregt, JJ; Higashi, H | 1 |
| Ashare, RL; McKee, SA | 1 |
| Baker, TB; Fiore, MC | 1 |
| Benowitz, NL; Bierut, LJ; Conti, DV; Kaprio, J; King, DP; Lerman, C; Paciga, S; Park, PW; Pickering, E | 1 |
| Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S | 1 |
| Fidler, J; Kotz, D; West, R | 1 |
| Lockhart, I; Mardle, T; Merrett, S; Percival, F; Wright, J | 1 |
| Coleman, T; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Ammerman, S; Bailey, SR; Crew, EE; Killen, JD; Riske, EC; Robinson, TN | 1 |
| Coleman, CI; Mahmoudi, M; Sobieraj, DM | 1 |
| Schuurmans, MM; Zellweger, JP | 1 |
| Cuesta, G; Lovato, P; Lutz, MA | 2 |
| Etter, JF; Schneider, NG | 1 |
| Larzelere, MM; Williams, DE | 1 |
| Ju, W; Jung, HS; Kim, H; Myung, SK; Oh, SW; Park, CH; Seo, H | 1 |
| Coster, TS; Graham, DJ; Meyer, TE; Moeny, D; Mosholder, AD; Ouellet-Hellstrom, RP; Taylor, LG; Williams, JR; Xie, S | 1 |
| Athanasakis, K; Igoumenidis, M; Karampli, E; Kyriopoulos, J; Sykara, G; Vitsou, E | 1 |
| Ebbert, JO; Lockhart, I; Mills, EJ; Puhan, M; Thorlund, K; Wu, P | 1 |
| Duaso, M; Duncan, D | 1 |
| Bansal-Travers, M; Borland, R; Cummings, KM; Fix, BV; Fong, GT; Hammond, D; Hyland, AJ; Kasza, KA; McNeill, AD | 1 |
| Holloway, AC; Nicholson, CJ; Raha, S; Woynillowicz, AK | 1 |
| Brown, VL; Cinciripini, PM; Cui, Y; Dani, JA; Engelmann, JM; Karam-Hage, M; Kosten, TR; Lam, CY; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Cesario, A; Granone, P; Lococo, F; Petracca-Ciavarella, L; Russo, P | 1 |
| Rigotti, NA | 1 |
| Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D | 1 |
| Abe, TO; Issa, JS; Moura, S; Pereira, AC; Santos, PC | 1 |
| Dautzenberg, B | 1 |
| Hviid, A; Pasternak, B; Svanström, H | 2 |
| Caudill, C; Dumire, W; Lewis, A; Morgan, SK | 1 |
| Almgren, MM; Clark, KJ; Stroman, RT; Wynn, WP | 1 |
| Lancaster, T; Stead, LF | 1 |
| Camarelles Guillem, F; Clemente Jiménez, L; Dalmau González-Gallarza, R; Díaz-Maroto Muñoz, JL; Lozano Polo, A; Pinet Ogué, MC | 1 |
| Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, S; Javitz, HS; Krasnow, R; Kwok, PY; Lee, W; Lerman, C; Liu, J; Michel, M; Nishita, D; Swan, GE; Tyndale, RF | 1 |
| Bernabé Barrios, MJ; Rodríguez Hermosa, JL; Santamaría Rodríguez, B; Zamarro García, C | 1 |
| Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I | 1 |
| Porwal, M; Tsoi, DT; Webster, AC | 1 |
| Aubin, HJ; Berlin, I; Luquiens, A | 1 |
| Brose, LS; Stapleton, JA; West, R | 1 |
| Fatemi, SH; Folsom, TD; Kneeland, RE; Liesch, SB; Thuras, PD; Yousefi, MK | 1 |
| Baker, MA; Brown, JS; Kornegay, C; Platt, R; Toh, S | 1 |
| Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Bölcskei, PL; Davis-Wagner, P; Grundnig, J; Pommer, P | 1 |
| Behm, FM; Rose, JE | 3 |
| Altet Gómez, N; Barrueco Ferrero, M; de Granda Orive, JI; Jiménez-Ruiz, CA; Lorza Blasco, JJ; Martinez Muñiz, MA; Ramos Pinedo, A; Riesco Miranda, JA; Signes-Costa Miñana, J; Solano Reina, S | 1 |
| Cahill, K; Lancaster, T; Perera, R; Stevens, S | 1 |
| Abella, F; Baena, A; Banque, M; Bullon, R; Carreras, JM; Comino, A; Jimenez-Muro, A; Marqueta, A; Masuet-Aumatell, C; Morchon, S; Nerin, I; Pinet, C; Ramon, JM; Vilarasau, A | 1 |
| Fagerström, KO; Jiménez-Ruiz, CA | 1 |
| Getsios, D; Ishak, KJ; Marton, JP; Revankar, N; Rublee, D; Ward, AJ; Willke, RJ; Xenakis, JG | 1 |
| Acuña, M; Bertoglia, MP; Bustamante, P; Cavada, G; Navarrete, S; Peña, P; Suárez, C; Zagolin, M | 1 |
| Brose, L; Brown, J; Herbec, A; Raupach, T; West, R | 1 |
| Aubin, HJ; Le Houezec, J | 1 |
| Trivedi, D | 1 |
| Clair, C; Rigotti, NA | 1 |
| Gibbons, RD; Mann, JJ | 1 |
| Boomershine, V; Haber, SL; Raney, E | 1 |
| Davies, NM; Gunnell, D; Martin, RM; Metcalfe, C; Thomas, KH; Windmeijer, F | 1 |
| Checa-Andrés, MD; Esparza-Martín, N; García-Cantón, C; Guerra-Rodríguez, R; Ramírez-Puga, A; Suria-González, S | 1 |
| Lerman, C; Perkins, KA | 1 |
| Eapen, S; Mills, EJ; Prochaska, JJ; Thorlund, K; Wu, P | 1 |
| Bobes, J; Diaz-Mesa, E; Elizagarate, E; Galvan, G; Garcia-Alvarez, L; Garcia-Blanco, J; Garcia-Portilla, MP; Saiz, PA; Sarramea, F | 1 |
| Brown, J; Kotz, D; West, R | 1 |
| Allen, SS; Croghan, IT; Ebbert, JO; Hatsukami, DK; Hays, JT; Hurt, RD; Schroeder, DR | 1 |
| Gupta, T; Jain, R; Majumder, P | 1 |
| Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
| Daughton, DM; Rennard, SI | 1 |
| Fahrenwald, NL; Kerkvliet, JL | 1 |
| Anderson, P; Johnson, M; Lockhart, I | 1 |
| Ebbert, JO; Elrashidi, MY | 1 |
| Amos, A; Ludbrook, A; McConville, S; Ormston, R; van der Pol, M | 1 |
| Arteaga, C; Brosky, G; Oh, P; Ranger, S; Raymond, V; Selby, P | 1 |
| Mendelsohn, CP; Richmond, RL; Zwar, NA | 1 |
| Rausch, R | 1 |
| Cahill, K; Hartmann-Boyce, J; Lancaster, T; Stead, LF | 1 |
| By, K; Graham, DJ; Kelman, JA; Kornegay, C; Levenson, M; MaCurdy, TE; McKean, S; Mosholder, A; Racoosin, JA; Worrall, C; Young, J | 1 |
| Kotz, D; Sheikh, A; Simpson, C; van Schayck, OC; Viechtbauer, W; West, R | 2 |
| Fisher, DC; Fletcher, PJ; Guy, EG; Higgins, GA | 1 |
| Ditre, JW; Farris, SG; Leventhal, AM; Schmidt, NB; Zvolensky, MJ | 1 |
| Barra, NG; De Long, NE; Hardy, DB; Holloway, AC | 1 |
| Brown, J; Ferguson, SG; Frandsen, M; West, R | 1 |
| Arbab-Zadeh, A; Garg, J; Krishnamoorthy, P; Lavie, CJ; Lichstein, E; Sharma, A; Sochor, O; Thakar, S | 1 |
| Ballbè, M; Cabezas, C; Fernández, E; Gual, A; Martínez, C; Riccobene, A; Saltó, E; Valverde, A | 1 |
| Akdağ, R; Buzgan, T; Çelik, İ; Erman, M; Hayran, M; Irmak, H; Kılıçkap, S; Tosun, N; Tuncer, M; Yüce, D | 1 |
| Broughton, AD; Hylick, EV; Smalls, TD; Woodard, TJ | 1 |
| Ebbert, JO; Elrashidi, MY; Hong, AS; Schroeder, DR | 1 |
| Hergel, LL; Nielsen, G; Poulsen, PB; Ringbæk, T; Spillemose, H; Strand, M; Wedell-Wedellsborg, D | 1 |
| Hall, BJ; Levin, ED; Rose, JE; Slade, S; Wells, C | 1 |
| van Boven, JF; Vemer, P | 1 |
| Aveyard, P; Farley, A; Hollands, GJ; Lindson-Hawley, N; McDermott, MS; Vogt, F | 1 |
| Boffi, R; Marabelli, C; Munarini, E; Pozzi, P | 1 |
| Abe, TO; Gaya, PV; Issa, JS; Krieger, JE; Pereira, AC; Santos, JR; Santos, PC; Tomaz, PR | 1 |
| Borse, MS; Brown, JD; Li, C; Shewale, AR | 1 |
| Borland, R; Maddox, S; Segan, CJ | 1 |
| Burkholder, GA; Clark, CB; Cropsey, KL; Jardin, BF; Raper, JL; Saag, MS | 1 |
| Azrin, ST; Baller, J; Daumit, GL; Juliano-Bult, D; McGinty, EE | 1 |
| Knudsen, HK; Roman, PM | 1 |
| Cummins, SE; Gamst, AC; Ikeda, T; Wong, S; Zhu, SH | 1 |
| He, Y; Sun, S; Wu, L; Zeng, J | 1 |
| Benowitz, NL; Prochaska, JJ | 1 |
| Fortmann, SP; Henderson, JT; Patnode, CD; Senger, CA; Thompson, JH; Whitlock, EP | 1 |
| Siu, AL | 1 |
| Miller, ME; Tidey, JW | 1 |
| Baydur, H; Budak, R; Choussein, B; Doğanay, S; Ergör, G; Günay, T; Pekel, Ö | 1 |
| Hussain, S; Selby, P; Voci, S; Zawertailo, L | 1 |
| Altet-Gomez, N; Barrueco, M; de Higes-Martinez, E; Granda-Orive, JI; Jiménez-Ruiz, CA; Lorza-Blasco, JJ; Oyagüez, I; Rejas, J; Riesco-Miranda, JA; Signes-Costa, J; Solano-Reina, S | 1 |
| Koilpillai, P; Lancaster, T; Stead, LF | 1 |
| Cather, C; Evins, AE | 1 |
| Ebbert, JO; Elrashidi, MY; Stead, LF | 1 |
| Eden Evins, A; McNeill, A; Roberts, E; Robson, D | 1 |
| Abughosh, SM; Chen, H; Essien, EJ; Johnson, ML; Peters, RJ; Wu, IH; Yang, M | 1 |
| Davies, GA; Leung, LW | 1 |
| Au, DH; Collins, MP; Feemster, LC; Melzer, AC | 1 |
| Chamberlain, C; Coleman, T; Cooper, SE; Davey, MA; Leonardi-Bee, J | 1 |
| Ebbert, JO; Little, MA | 1 |
| Abe, TO; Gaya, PV; Pereira, AC; Pinheiro, GG; Santos, PC; Scholz, J; Silva, AP | 1 |
| Seguí Díaz, M | 1 |
| Evoy, KE; McClain, C; Vogeler, T | 1 |
| Brose, LS; McEwen, A | 1 |
| Bahadir, A; Bakan, ND; Iliaz, S; Ortakoylu, MG; Yazar, E; Yurt, S | 1 |
| Banks, ML; Blough, BE; Smith, DA | 1 |
| Aveyard, P; Hartmann-Boyce, J | 1 |
| Prochaska, JJ | 1 |
| Abughosh, S; Chen, H; Essien, EJ; Johnson, ML; Peters, RJ; Wang, X; Yang, M | 1 |
| Aumann, I; Hagemann, N; Treskova, M; von der Schulenburg, JM | 1 |
| Hyon Baik, S; Jarlenski, M; Zhang, Y | 1 |
| Anthenelli, RM; Ascher, J; Benowitz, NL; Evins, AE; Krishen, A; Lawrence, D; McRae, T; Russ, C; St Aubin, L; West, R | 1 |
| Zawertailo, L | 1 |
| Cahill, K; Fanshawe, TR; Lancaster, T; Lindson-Hawley, N; Thomas, KH | 1 |
| Abe, TO; Amorim, C; Buzo, CG; Gaya, PV; Lopes, NH; Pereira, AC; Pierri, H; Santos, PC; Scholz, J | 1 |
| Blazekovic, S; Brubaker, TR; Hitsman, B; Hole, A; Kalhan, R; Langer, C; Leone, F; Patel, J; Price, S; Schnoll, R; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Klein, JW | 1 |
| Ban, N; Hamajima, N; Hasegawa, Y; Murohara, T; Oguri, T; Okada, Y; Sato, M; Shimadu, S | 1 |
| Ojo, O; Temitayo Orisasami, I | 1 |
| Kotz, D; van der Meer, RM; van Eerd, EA; van Schayck, OC | 1 |
| Aitken, D; Mullen, KA; Pipe, AL; Pritchard, G; Reid, RD; Walker, K | 1 |
| Gass, JC; Germeroth, LJ; Hawk, LW; Moore, FE; Motschman, CA; Munoz, DA; Rhodes, JD; Schlienz, NJ; Tiffany, ST; Wray, JM | 1 |
| Muheim, L | 1 |
| Burkholder, G; Cropsey, KL; McClernon, FJ; Mugavero, MJ; O'Cleirigh, C; Valera, P; Willig, J | 1 |
| Cristóbal Fernández, M; de Granda Orive, JI; de Higes Martinez, E; Garcia Rueda, M; Jiménez Ruiz, CA; Lorza Blasco, JJ; Pascual Lledó, JF; Riesco Miranda, JA; Signes Costa-Miñana, J; Solano Reina, S; Valencia Azcona, B; Villar Laguna, C | 1 |
| Eberg, M; Eisenberg, MJ; Filion, KB; Gore, GC; Grad, R; Joseph, L; Larivière, J; Reynier, PM; Suissa, K | 1 |
| Cinciripini, PM; Engelmann, JM; Green, CE; Karam-Hage, M; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Bagci, BA; Bahadir, A; Chousein, EGU; Hattatoglu, DG; Iliaz, S; Ortakoylu, MG; Tanriverdi, E; Tural Onur, S; Uysal, MA; Yurt, S | 1 |
| Jacobson, LT; Richter, KP; Scheuermann, TS; Shireman, TI | 1 |
| Kotz, D; Sheikh, A; Simpson, CR; van Schayck, OCP; Viechtbauer, W; West, R | 1 |
| Baraona, LK; Daniels, JL; Lovelace, D; McDaniel, L | 1 |
| Acuña Izcaray, A; Alfageme Michavila, I; Buljubasich, D; Casas, A; Chatkin, JM; de Granda Orive, JI; Guerreros Benavides, A; Jiménez Ruiz, CA; Noé, V; Núñez-Sánchez, I; Paez Espinel, N; Palomar Lever, A; Riesco Miranda, JA; Sánchez-Angarita, E; Sansores, RH; Zabert, G | 1 |
| Galanti, MR; Hansson, J; Janszky, I; Möller, J; Monárrez-Espino, J; Söderberg-Löfdal, K | 1 |
| Sambamoorthi, U; Shah, A; Shah, D; Tan, X | 1 |
| Auer, R; Cardinaux, R; Cornuz, J; Jacot Sadowski, I; Jakob, J; Selby, K | 1 |
| Brabyn, S; Cook, L; Gilbody, S; Peckham, E; Tew, G | 1 |
| Gulati, M; Hellkamp, A; Pagidipati, NJ; Peterson, ED; Thomas, L; Wang, TY | 1 |
| Bruguera, E; Cedillo, S; Rejas-Gutiérrez, J | 1 |
| Carroll, M; de Andrade, D; Kinner, SA; Puljević, C; Spittal, MJ | 1 |
| Kress, CM; Obi, NU; Prochazka, AV | 1 |
| An, H; He, Y; Jiang, B; Liu, Q; Wu, L; Zhang, L; Zhou, C; Zuo, F | 1 |
| Boffi, R; Colombo, F; Galvan, A; Noci, S; Pasetti, G; Pastorino, U; Pintarelli, G; Pozzi, P; Sala, F | 1 |
| Cinciripini, PM; Cui, Y; Deweese, MM; Engelmann, JM; Green, CE; Karam-Hage, M; Lam, CY; Minnix, JA; Robinson, JD; Stevens, EM; Versace, F; Wetter, DW | 1 |
| Cinciripini, PM; Cui, Y; Engelmann, JM; Karam-Hage, M; Lam, CY; Minnix, JA; Robinson, JD; Xian, J | 1 |
| Latimer, KM | 1 |
| Freedman, LS; Galili, T; Goodman, M; Kott, J; Rosen, LJ | 1 |
| Anthenelli, RM; Benowitz, NL; Evins, AE; Krishen, A; Lawrence, D; Maravic, MC; McRae, T; Russ, C; St Aubin, L; West, R | 1 |
| Eisenberg, MJ; Filion, KB; Franck, C | 1 |
| Coleman, T; Jones, M; Turner, E; Vaz, LR | 1 |
| Jordan, CJ; Xi, ZX | 1 |
| Anthenelli, RM; Benowitz, NL; Hays, JT; Lawrence, D; McRae, T; Pipe, A; St Aubin, L; Tonstad, S; West, R | 1 |
| Abdul-Kader, J; Airagnes, G; D'almeida, S; Le Faou, AL; Limosin, F | 1 |
| Bambs S, C; Cerda L, J; Corvalán B, MP; Pavié G, J; Véjar M, L; Zagolin B, M | 1 |
| Kathuria, H; Leone, FT; Neptune, ER | 1 |
| Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Underner, M | 1 |
| Clark, AJ; Johnsen, SP; Lange, P; Thomsen, RW; Tøttenborg, SS | 1 |
| Aveyard, P; Coleman, T; Hajek, P; Lewis, S; Lindson, N; Munafo, M | 1 |
| Bozinoff, N; Le Foll, B | 1 |
| Bondy, SJ; Chaiton, M; Cohen, JE; Diemert, LM; Ferrence, RG; Fung, MD; Zhang, BR | 1 |
| Hollenbeak, CS; Kulaylat, AS; Soybel, DI | 1 |
| Barboza, J | 1 |
| Hughes, JR; Klemperer, EM; Naud, S | 1 |
| El-Mallakh, P; Okoli, CTC; Seng, S | 1 |
| Achenbach, C; Akanbi, MO; Bilaver, LA; Carroll, AJ; Hitsman, B; Jordan, N; McHugh, MC; Murphy, R; O'Dwyer, LC | 1 |
| Benowitz, NL; Kalkhoran, S; Rigotti, NA | 1 |
| Charntikov, S; Kazan, T | 1 |
| Brown, J; Jackson, SE; McGowan, JA; Proudfoot, H; Shahab, L; Ubhi, HK; West, R | 1 |
| Leischow, SJ | 1 |
| Bennett, DA; Bergen, AW; David, SP; Munafò, MR; Panagiotou, OA; Schuit, E | 1 |
| Hajek, P; Hartmann-Boyce, J; Jarvis, M; Livingstone-Banks, J; Norris, E; West, R | 1 |
| García-Gómez, L; Hernández-Pérez, A; Jiménez-Ruiz, C; Noé-Díaz, V; Riesco-Miranda, JA | 1 |
| Anthenelli, RM; Benowitz, NL; Evins, AE; Gaffney, M; Krishen, A; Lawrence, D; McRae, T; Russ, C; St Aubin, L; West, R | 1 |
| Baker, TB; Bierut, LJ; Chen, LS; Culverhouse, RC; Ma, Y; Piper, ME; Saccone, NL | 1 |
| Barnett, PG; Duffy, SA; Essenmacher, CA; Geraci, MC; Hall, SV; Ignacio, RV; Kim, HM; Sherman, SE | 1 |
| Brath, H; Fasching, P; Kaser, S; Tatschl, C | 1 |
| Brown, J; Jackson, SE; Kotz, D; West, R | 1 |
| Brousse, G; de Chazeron, I; Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Schmitt, A; Underner, M | 1 |
| Fanshawe, TR; Hartmann-Boyce, J; Hong, B; Livingstone-Banks, J; Wheat, H | 1 |
| Anthenelli, RM; Aubin, LS; Ayers, CR; Evins, AE; Heffner, JL; Krishen, A; Lawrence, D; McRae, T; Russ, C; West, R | 1 |
| Guichenez, P; Perriot, J; Underner, M | 1 |
| Cornuz, J; Jacot Sadowski, I; Rat, C; Selby, K | 1 |
| Choi, J; Jo, MW; Paek, YJ; Seo, YG | 1 |
| Gendy, MNS; Ibrahim, C; Le Foll, B; Sloan, ME | 1 |
| Adermark, L; Danielsson, K; de Bejczy, A; Ericson, M; Söderpalm, B | 1 |
| Eberg, M; Filion, KB; Platt, RW; Reynier, P | 1 |
| Xia, S; Zhao, S; Zhao, Y; Zhong, Z | 1 |
| Havard, A; Kennedy, D; Lee, ML; Tran, DT; Welsh, A | 1 |
| George, TP; Kozak, K | 1 |
| Alebshehy, R; AlMulla, A; El-Awa, F; Fraser, CP; Fu, D; Hassan-Yassoub, N; Ismail, M | 1 |
| Bassett, K; Carney, G; Dormuth, CR; Maclure, M; Taylor, S | 1 |
| Charntikov, S; Cova, N; Kazan, T; Madore, VM; Robison, CL | 1 |
| Abney, LR; Adams, DW; Beaulieu, DB; Freiberg, MS; Gatskie, V; Gurwara, S; Horst, SN; King, S; Peyton, SC; Pointer, SO; Schwartz, DA; Scoville, EA; Tindle, HA; Wells, QS | 1 |
| Hartmann-Boyce, J; Hong, B; Howes, S; Lindson, N; Livingstone-Banks, J | 1 |
| Elkind, MSV; Kamel, H; Parikh, NS; Salehi Omran, S; Willey, JZ | 1 |
| Mathieson, K; Olawuyi, O | 1 |
| Jiang, Y; Kuang, D; Xiao, L; Xie, L; Yang, Y | 1 |
| Filipponi, A; Giordano, P; Giulietti, F; Iacoacci, C; Rosettani, G; Sarzani, R; Spannella, F | 1 |
| Kenny, PJ; O'Brien, CP; Pierce, RC; Swinford-Jackson, SE; Unterwald, EM; Vanderschuren, LJMJ | 1 |
| Cruz-Lopes, L; Eakin, MN; Evers-Casey, S; Evins, AE; Farber, HJ; Fathi, J; Fennig, K; Folan, P; Fulone, I; Galiatsatos, P; Gogineni, H; Kantrow, S; Kathuria, H; Lamphere, T; Leone, FT; Murray, RL; Neptune, E; O'Brien, KK; Pacheco, MC; Pakhale, S; Pavalagantharajah, S; Prezant, D; Ross, S; Sachs, DPL; Toll, B; Upson, D; Xiao, D; Zhang, Y; Zhu, M | 1 |
| George, O; Smith, LC | 1 |
| Firth, J; Kisely, S; Siskind, DJ; Wong, TT; Wu, BT | 1 |
| Benipal, S; Bilimoria, K; Budhram, DR; Persaud, N; Wang, R; Woods, H | 1 |
| Borderud, S; Cooley, ME; de León-Sanchez, S; Friedman, ER; Gonzalez, I; Holland, S; Hyland, KA; Irwin, KE; Kwon, D; Levy, DE; Malloy, L; Miller-Sobel, J; Muzikansky, A; O'Brien, M; Ostroff, JS; Park, ER; Partridge, AH; Perez, GK; Peterson, L; Pirl, WF; Ponzani, C; Rabin, J; Regan, S; Rigotti, NA; Sprunck, K; Temel, JS; Whitlock, CW | 1 |
| Anthenelli, RM; Benowitz, NL; Evins, AE; Heffner, JL; Lawrence, D; Maravic, MC; McRae, T; Russ, C; West, R | 1 |
| Davies, NM; Douglas, I; Gunnell, D; Martin, RM; Taylor, AE; Taylor, GMJ; Thomas, KH | 1 |
| Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC | 1 |
| Ahluwalia, JS; Benowitz, NL; Lawrence, D; Nollen, NL; Okuyemi, K; Samuels, L; Sanderson Cox, L | 1 |
| Bonevski, B; Walker, N | 1 |
| Anthenelli, RM; Correa, JB; Doran, N; Dubrava, S; Gaznick, N; Lawrence, D; McKenna, BS; Saccone, PA | 1 |
| Anthenelli, RM; Aubin, LS; Beard, E; Benowitz, NL; Evins, AE; Jackson, SE; Krishen, A; Lawrence, D; McRae, T; Russ, C; West, R | 1 |
| Boezen, HM; Bos, JH; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B | 1 |
| Dutro, MP; Ebbert, J; Fisher, M; Hays, JT; Jimenez-Ruiz, C; Li, J | 1 |
| Caldwell, DM; Dalili, MN; Keeney, E; López-López, JA; Munafò, MR; Phillippo, DM; Stevenson, M; Thomas, KH; Welton, NJ | 2 |
| de Chazeron, I; Jaafari, N; Peiffer, G; Perriot, J; Ruppert, AM; Underner, M | 1 |
| Boezen, HM; Bos, JHJ; Hak, E; Schuiling-Veninga, CCM; van Boven, JFM; Wang, Y; Wilffert, B | 1 |
| Babazono, A; Fujita, T; Jamal, A; Jiang, P; Li, Y | 1 |
| Goldman, RD; Yan, T | 1 |
| Evers-Casey, S; Leone, FT | 1 |
| Choi, SKY; Chow, CK; Filion, KB; Havard, A; Pearson, SA; Tran, DT | 1 |
| Hartmann-Boyce, J; Kruse, GR; Livingstone-Banks, J; Rigotti, NA | 1 |
| Hussain, S; Le Foll, B; Mansoursadeghi-Gilan, T; Selby, P; Veldhuizen, S; Zawertailo, L; Zhang, H | 1 |
| E, F; Guo, K; Hou, L; Li, J; Li, X; Li, Y; Shang, X; Wang, S; Yang, K | 1 |
| Anthenelli, RM; Beneventi, D; Blalock, JA; Cinciripini, PM; Green, C; Karam-Hage, M; Kypriotakis, G; Lawrence, D; Minnix, J; Morris, C | 1 |
| Abramson, MJ; Bonevski, B; George, J; Gobarani, RK; Ilomäki, J; Wood, S | 1 |
| Perkins, KA | 1 |
| Humair, JP; Papachristou, C | 1 |
| Bauld, L; Beard, E; Brown, J; Kock, L; Shahab, L; Tattan-Birch, H; West, R | 1 |
| Chang, CT; Choo, SJ; Harun, SN; Latif, MFA; Sanusi, NA; Tangiisuran, B | 1 |
| Kang, DW; Lee, EK; Park, SK | 1 |
| Hendershot, CS; Zaso, MJ | 1 |
| Fulone, I; Kathuria, H; Leone, FT; Lopes, LC; Murray, RL; O'Brien, KK; Pavalagantharajah, S; Ross, S; Sachs, DPL; Zhang, Y; Zhang, YQ; Zhu, M | 1 |
| Baliunas, D; Comans, T; Gartner, C; Hollingworth, SA; Pole, JD; Sullivan, C | 1 |
| E, F; Guo, K; Li, M; Li, X; Li, Y; Shang, X; Wang, Y; Wu, Y; Xu, M; Yang, C; Yang, K; Zhou, L | 1 |
| Daumit, GL; McGinty, EE; Murphy, KA; Stone, E; White, SA | 1 |
| Dakkak, M; Gaddey, HL; Jackson, NM | 1 |
| Gilbert, E; Hussain, S; Le Foll, B; Selby, P; Veldhuizen, S; Zawertailo, L; Zhang, H | 1 |
| Barrett, ST; Bevins, RA; Dwoskin, LP; Huynh, YW; Thompson, BM; Tracy, ME | 1 |
| Bahnisch, J; Demirkol, A; Lin, C; Lobbe, C; Murnion, B | 1 |
| Laucho-Contreras, ME; Montes de Oca, M | 1 |
| Kumamaru, H; Matsuyama, Y; Takeuchi, Y; Yokoyama, R | 1 |
| Cinciripini, P; Green, C; Hwang, LY; Lerman, C; Pedroza, C; Rajan, SS; Suchting, R; Truong, VTT; Tyndale, RF | 1 |
| Eisenberg, MJ; Huerne, K | 1 |
| Fanshawe, TR; Hajizadeh, A; Hartman, L; Lindson, N; Livingstone-Banks, J; Theodoulou, A; Thomas, KH | 1 |
| Agarwal, A; Das, M; Jaiswal, PL; Kashyap, P | 1 |
| Hajizadeh, A; Hartmann-Boyce, J; Howes, S; Klemperer, E; Lindson, N; Livingstone-Banks, J; Theodoulou, A | 1 |
| Asfar, T; Bursac, Z; Eissenberg, T; Ghaddar, T; Livingstone-Banks, J; Maziak, W; Oluwole, O; Ward, KD | 1 |
| Eisenberg, MJ; Moiz, A | 1 |
| Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Greiner, KA; Leavens, ELS; Mayo, MS; Nollen, NL; Salzman, G; Shanks, D; Woodward, J | 1 |
| Deng, X; E, F; Guo, K; Li, X; Liang, S; Liu, W; Shang, X; Wang, Y; Wang, Z; Wu, Y; Yang, K; Zhou, L | 1 |
| Cabrera-César, E; de Granda-Orive, JI; De Higes-Martínez, E; García Rueda, M; Jiménez-Ruiz, CA; Pastor-Esplá, E; Rábade-Castedo, C; Ramos-Pinedo, Á; Riesco-Miranda, JA; Signes-Costa Miñana, J | 1 |
| Dennis, BB; Devereaux, PJ; Fairbairn, N; Lu, C; Mbuagbaw, L; Ofori, S; Olasupo, OO | 1 |
| Davis, JM; Masclans, L; Rose, JE | 1 |
| Agrawal, S; Aveyard, P; Fanshawe, TR; Freeman, SC; Hajizadeh, A; Hartmann-Boyce, J; Lindson, N; Livingstone-Banks, J; Ordóñez-Mena, JM; Sutton, AJ; Theodoulou, A; Zhu, S | 1 |
166 review(s) available for bupropion and varenicline
| Article | Year |
|---|---|
Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.
Topics: Alkaloids; Antidepressive Agents; Azetidines; Azocines; Depression; Humans; Ligands; Molecular Targeted Therapy; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Receptors, Nicotinic | 2014 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic interventions for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline | 2006 |
Varenicline: a review of its use as an aid to smoking cessation therapy.
Topics: Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Humans; Quinoxalines; Smoking Cessation; Varenicline | 2006 |
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2006 |
Non-nicotinic therapies for smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Directive Counseling; Hospitalization; Humans; Neurotransmitter Uptake Inhibitors; Nicotinic Agonists; Nortriptyline; Quinoxalines; Referral and Consultation; Risk Reduction Behavior; Smoking; Smoking Cessation; Varenicline | 2007 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Hospitalization; Humans; Internet; Physician's Role; Practice Patterns, Physicians'; Quinoxalines; Receptors, Nicotinic; Risk Reduction Behavior; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
[Varenicline--a new drug for smoking cessation].
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
Topics: Age Factors; Benzazepines; Bupropion; Complementary Therapies; Dopamine Uptake Inhibitors; Dosage Forms; Humans; Nicotine; Nicotinic Agonists; Physician's Role; Primary Health Care; Quinoxalines; Referral and Consultation; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Smoking cessation: lessons learned from clinical trial evidence.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2007 |
Optimizing on smoke free legislation making the most of the opportunity.
Topics: Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Nurse's Role; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Public Facilities; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; United Kingdom; Varenicline | 2007 |
Treating tobacco dependence in women.
Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline; Women's Health | 2007 |
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Partial Agonism; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2007 |
Treatment of tobacco dependence: integrating recent progress into practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Health Behavior; Health Policy; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Breaking the ties of nicotine dependence.
Topics: Algorithms; Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Primary Health Care; Quinoxalines; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
An update on therapeutics for tobacco dependence.
Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline | 2008 |
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2008 |
Smoking cessation and lung cancer: oncology nurses can make a difference.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Information Services; Lung Neoplasms; Nicotine; Oncology Nursing; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People | 2008 |
Smoking cessation in pregnancy: why, how, and what next...
Topics: Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Nicotine; Pregnancy; Pregnancy Outcome; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
[The ABC of smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Humans; Hypnosis; Motivation; Nicotiana; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Which drug to be used in smoking cessation?
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2008 |
The relevance and treatment of cue-induced cravings in tobacco dependence.
Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cues; Extinction, Psychological; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Drugs for tobacco dependence.
Topics: Adrenergic alpha-Agonists; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Topics: Animals; Behavior, Addictive; Benzazepines; Bupropion; Ganglionic Stimulants; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Quinoxalines; Smoking; Tobacco Use Disorder; Varenicline | 2009 |
[Modern medical support for smoking cessation].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
[Not smoking, essential for healthy lungs].
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Chewing Gum; Health; Humans; Lung; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tablets; Varenicline | 2008 |
Smoking cessation in pregnancy.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
New findings on nicotine addiction and treatment.
Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Tobacco smoking cessation management: integrating varenicline in current practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Drug Partial Agonism; Health Policy; Humans; Nicotinic Agonists; Public Policy; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Pharmacotherapy for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Benzazepines; Bupropion; Humans; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Randomized Controlled Trials as Topic; Rimonabant; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
A preliminary benefit-risk assessment of varenicline in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2009 |
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
Topics: Animals; Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Varenicline: a first-line treatment option for smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Drug Partial Agonism; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Update on smoking cessation therapies.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost of Illness; Drug Approval; Global Health; Humans; Morbidity; Nicotine; Nicotinic Agonists; Quinoxalines; Safety; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United States; Varenicline | 2009 |
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
Pharmacogenetics of smoking cessation therapy.
Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; Pharmacogenetics; Quinoxalines; Smoking Cessation; Varenicline | 2010 |
Tobacco use among individuals with intellectual or developmental disabilities: a brief review.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Disabled Persons; Health Policy; Humans; Nicotine; Persons with Mental Disabilities; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States; Varenicline | 2009 |
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
Topics: Animals; Antioxidants; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Maternal-Fetal Exchange; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Respiratory System; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
Topics: Animals; Benzazepines; Bupropion; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Nicotine; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2009 |
Varenicline in the management of smoking cessation: a single technology appraisal.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Humans; Nicotinic Agonists; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Nicotine dependence and smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Current approaches to pharmacotherapy for smoking cessation.
Topics: Adolescent; Adult; Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline | 2010 |
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Health Care Costs; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Prevalence; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Smoking cessation intervention: an evidence-based approach.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Directive Counseling; Drug Therapy, Combination; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2010 |
Improving the effectiveness of tobacco use cessation (TUC).
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Chewing Gum; Counseling; Dental Offices; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Referral and Consultation; Smoking; Tobacco Use Cessation; Varenicline | 2010 |
Smoking cessation-recent advances.
Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline | 2010 |
Comparison of available treatments for tobacco addiction.
Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2010 |
[Preventive relapse treatment for tobacco cessation - is it worthwhile?].
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2010 |
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
Topics: Benzazepines; Bupropion; Genetic Variation; Humans; Nicotine; Protein Subunits; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2010 |
Interventions for smokeless tobacco use cessation.
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline | 2011 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2011 |
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2011 |
Pharmacotherapy for smoking cessation: present and future.
Topics: Adolescent; Animals; Benzazepines; Bupropion; Delayed-Action Preparations; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2011 |
Clinical practice. Treating smokers in the health care setting.
Topics: Benzazepines; Bupropion; Cholinergic Agents; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Humans; Middle Aged; Motivation; Nicotine; Patient Compliance; Physician-Patient Relations; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2011 |
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Topics: Adolescent; Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Prescription Drugs; Quinoxalines; Randomized Controlled Trials as Topic; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Humans; Markov Chains; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline | 2012 |
[Smoking cessation in medical practice--new possibilities?].
Topics: Benzazepines; Bupropion; Complementary Therapies; Drugs, Investigational; General Practitioners; Humans; Nicotine; Nicotinic Agonists; Professional Practice; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2012 |
Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis.
Topics: Adult; Benzazepines; Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Epidemiologic Methods; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2012 |
Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.
Topics: Benzazepines; Bupropion; Databases, Bibliographic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Nicotinic Antagonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Health impact of smoking and smoking cessation strategies: current evidence.
Topics: Benzazepines; Bupropion; Cause of Death; Counseling; Evidence-Based Medicine; Humans; Nicotinic Agonists; Nurse's Role; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Tobacco Use Cessation Devices; United Kingdom; Varenicline | 2012 |
The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Education, Pharmacy, Continuing; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pharmacists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2012 |
Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
[Smoking in COPD].
Topics: Benzazepines; Bupropion; Clonidine; Comorbidity; Disease Progression; Europe; Humans; Motivation; Nicotinic Agonists; Nortriptyline; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2011 |
[Drugs used to treat nicotine addiction].
Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult | 2012 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking cessation and COPD.
Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.
Topics: Adolescent; Benzazepines; Bupropion; Counseling; Drug Design; Female; Humans; Molecular Sequence Data; Pregnancy; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
[Current approaches to smoking cessation].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cooperative Behavior; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Germany; Health Priorities; Health Surveys; Humans; Interdisciplinary Communication; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2013 |
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Topics: Adult; Alkaloids; Antidepressive Agents, Second-Generation; Azocines; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Review Literature as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
A systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Medication Adherence; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Cochrane review summary: Pharmacological interventions for promoting smoking cessation during pregnancy.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Birth Weight; Bupropion; Female; Humans; Infant, Newborn; Medication Adherence; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Managing tobacco use: the neglected cardiovascular disease risk factor.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Counseling; Female; Health Promotion; Humans; Male; Nicotinic Agonists; Physician's Role; Quinoxalines; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Safety of varenicline in patients with cardiovascular disease.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2014 |
An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Clinical Trials, Phase II as Topic; Cross-Over Studies; Drug Evaluation, Preclinical; Feasibility Studies; Humans; Quinoxalines; Research Design; Smoking Cessation; Validation Studies as Topic; Varenicline | 2014 |
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Topics: Adult; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2014 |
Pharmacological intervention of nicotine dependence.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; School Health Services; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Is it safe to use smoking cessation therapeutics during pregnancy?
Topics: Animals; Benzazepines; Bupropion; Female; Humans; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2014 |
Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
Topics: Benzazepines; Bupropion; Chest Pain; Dose-Response Relationship, Drug; Humans; Hypertension; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Randomized Controlled Trials as Topic; Seizures; Smoking Cessation; Smoking Prevention; Tachycardia; Varenicline | 2015 |
Interventions to increase adherence to medications for tobacco dependence.
Topics: Benzazepines; Bupropion; Drug Therapy, Combination; Humans; Medication Adherence; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review.
Topics: Behavior Therapy; Bipolar Disorder; Bupropion; Cardiovascular Diseases; Diabetes Mellitus; Dopamine Uptake Inhibitors; Health Behavior; HIV Infections; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Metformin; Motor Activity; Nicotinic Agonists; Obesity; Overweight; Risk Reduction Behavior; Schizophrenia; Smoking; Smoking Cessation; Varenicline | 2016 |
Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
Topics: Adult; Aged; Benzazepines; Bupropion; Female; Humans; Intention; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2015 |
The Past, Present, and Future of Nicotine Addiction Therapy.
Topics: Alkaloids; Azocines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Policy; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Social Media; Text Messaging; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force.
Topics: Adult; Behavior Therapy; Bupropion; Counseling; Electronic Nicotine Delivery Systems; Female; Humans; Nicotinic Agonists; Pregnancy; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline | 2015 |
Smoking cessation and reduction in people with chronic mental illness.
Topics: Anxiety Disorders; Bipolar Disorder; Bupropion; Electronic Nicotine Delivery Systems; Humans; Mental Disorders; Mentally Ill Persons; Nicotinic Agonists; Prevalence; Reinforcement, Psychology; Schizophrenia; Smoking; Smoking Cessation; Stress Disorders, Post-Traumatic; Tobacco Use Cessation Devices; United Kingdom; United States; Varenicline | 2015 |
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Effective Cessation Strategies for Smokers with Schizophrenia.
Topics: Antipsychotic Agents; Behavior Therapy; Bupropion; Humans; Schizophrenia; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Interventions for smokeless tobacco use cessation.
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline | 2015 |
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
Topics: Bupropion; Humans; Mental Disorders; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2016 |
Smoking Cessation Strategies in Pregnancy.
Topics: Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotinic Agonists; Pregnancy; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Pharmacological interventions for promoting smoking cessation during pregnancy.
Topics: Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
The safety of treatments for tobacco use disorder.
Topics: Bupropion; Delayed-Action Preparations; Humans; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Cardiac adverse effects of nicotine replacement therapy.
Topics: Bupropion; Cardiovascular Diseases; Humans; Tobacco Use Cessation Devices; Varenicline | 2015 |
Combination bupropion SR and varenicline for smoking cessation: a systematic review.
Topics: Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Smoking Cessation; Varenicline | 2016 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2016 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Evaluating the effectiveness of smoking cessation in the management of COPD.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Humans; Nicotinic Agonists; Nurse's Role; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Varenicline | 2016 |
Smoking cessation for people with chronic obstructive pulmonary disease.
Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2016 |
Managing smoking cessation.
Topics: Aftercare; Behavior Therapy; Bupropion; Canada; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline.
Topics: Adult; Bupropion; Clinical Trials as Topic; Female; Humans; Laboratories; Middle Aged; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Varenicline | 2016 |
Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
Topics: Bupropion; Cardiovascular Diseases; Counseling; Humans; Network Meta-Analysis; Nicotinic Agonists; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Varenicline | 2017 |
Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.
Topics: Bupropion; Female; Fetus; Humans; Lactation; Nicotiana; Nicotine; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Mental Disorders; Nicotinic Agonists; Smoking; Smoking Cessation; Varenicline | 2017 |
Lung Cancer: Smoking Cessation.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Mass Screening; Nicotinic Agonists; Psychotherapy, Group; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2018 |
Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
Topics: Bupropion; Humans; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2018 |
Smoking Cessation in Patients With Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Behavior Therapy; Bupropion; Cardiac Rehabilitation; Counseling; Electronic Nicotine Delivery Systems; Humans; Motivation; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2018 |
Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy.
Topics: Bupropion; Case-Control Studies; Female; Humans; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2019 |
Discovery and development of varenicline for smoking cessation.
Topics: Animals; Bupropion; Drug Development; Drug Discovery; Humans; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2018 |
[Interventions for smoking cessation in 2018].
Topics: Bupropion; History, 21st Century; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2018 |
Treatment of tobacco dependence: current state of the art.
Topics: Bupropion; Directive Counseling; Early Detection of Cancer; Humans; Lung Neoplasms; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2018 |
[Smoking cessation: Pharmacological strategies different from standard treatments].
Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Standard of Care; Tobacco Use Cessation Devices; Varenicline | 2018 |
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.
Topics: Bupropion; Combined Modality Therapy; Humans; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2018 |
Pharmaceutical strategies for smoking cessation during pregnancy.
Topics: Bupropion; Female; Humans; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2018 |
Study Characteristics Influence the Efficacy of Substance Abuse Treatments: A Meta-analysis of Medications for Smoking Cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Smoking Cessation; Smoking Cessation Agents; Substance-Related Disorders; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2020 |
The efficacy of smoking cessation interventions in low- and middle-income countries: a systematic review and meta-analysis.
Topics: Adult; Behavior Therapy; Bupropion; Cigarette Smoking; Clonidine; Counseling; Developing Countries; Humans; Mobile Applications; Naltrexone; Nortriptyline; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.
Topics: Bupropion; Cigarette Smoking; Health Promotion; Humans; Smoking Cessation; Tobacco Use; Tobacco Use Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2018 |
Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
Topics: Biobehavioral Sciences; Bupropion; Follow-Up Studies; Humans; Randomized Controlled Trials as Topic; Recurrence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
Topics: Bupropion; Clinical Trials as Topic; Female; Genetic Markers; Genotype; Humans; Male; Polymorphism, Single Nucleotide; Prospective Studies; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
Relapse prevention interventions for smoking cessation.
Topics: Behavior Therapy; Bupropion; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Cessation Agents; Smoking Prevention; Varenicline | 2019 |
SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS.
Topics: Bupropion; Cognitive Behavioral Therapy; Humans; Mexico; Motivational Interviewing; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
[Smoking, alcohol and diabetes (Update 2019)].
Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
[Stopping and reducing smoking in patients with schizophrenia].
Topics: Bupropion; Cognitive Behavioral Therapy; Electronic Nicotine Delivery Systems; Humans; Nicotine; Reinforcement, Psychology; Schizophrenia; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2019 |
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
Topics: Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2019 |
[Behavioral and cognitive therapies in smoking cessation: What tools for the pulmonologist?]
Topics: Behavior Therapy; Bupropion; Cognitive Behavioral Therapy; Humans; Motivation; Pulmonary Medicine; Pulmonologists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
[Smoking cessation: How can we involve patients better in treatment choice?]
Topics: Bupropion; Choice Behavior; Counseling; Decision Making, Shared; Humans; Nicotine; Patient Participation; Patient Selection; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade.
Topics: Bupropion; Humans; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2020 |
Drugs for smoking cessation.
Topics: Bupropion; Humans; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2019 |
Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
Topics: Adult; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Varenicline | 2019 |
Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2020 |
Antidepressants for smoking cessation.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Bupropion; Humans; Nortriptyline; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2020 |
Smoking-cessation pharmacotherapy for patients with stroke and TIA: Systematic review.
Topics: Bupropion; Female; Humans; Ischemic Attack, Transient; Observational Studies as Topic; Randomized Controlled Trials as Topic; Seizures; Smoking; Smoking Cessation; Stroke; Tobacco Use Cessation Devices; Varenicline | 2020 |
Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
Topics: Alkaloids; Azocines; Bupropion; Clinical Decision-Making; Electronic Nicotine Delivery Systems; Humans; Quinolizines; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2020 |
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.
Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Receptors, Nicotinic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2020 |
Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Network Meta-Analysis; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Varenicline | 2020 |
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.
Topics: Bupropion; Cost-Benefit Analysis; Depression; Drug Costs; Electronic Nicotine Delivery Systems; Humans; Markov Chains; Models, Economic; Monte Carlo Method; Network Meta-Analysis; Nicotinic Agonists; Quality-Adjusted Life Years; Recurrence; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline | 2021 |
[Combinations of pharmacological treatments in smoking cessation. A systematic review].
Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Varenicline | 2021 |
Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials.
Topics: Adult; Bayes Theorem; Bupropion; Electronic Nicotine Delivery Systems; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2022 |
Tobacco Use Disorder.
Topics: Behavior, Addictive; Bupropion; Combined Modality Therapy; Counseling; Drug Therapy; Electronic Nicotine Delivery Systems; Humans; Morbidity; Neurobiology; Nicotine; Nicotinic Agonists; Phenotype; Prevalence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2022 |
Treatment of Tobacco Smoking: A Review.
Topics: Behavior Therapy; Bupropion; Drug Therapy, Combination; Electronic Nicotine Delivery Systems; Humans; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2022 |
The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials.
Topics: Bupropion; Humans; Network Meta-Analysis; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Effects of varenicline and bupropion on laboratory smoking outcomes: Meta-analysis of randomized, placebo-controlled human laboratory studies.
Topics: Bupropion; Humans; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2022 |
Varenicline for Tobacco-Dependent Adults Who Are Not Ready to Discontinue Use: A Systematic Review and Meta-Analysis.
Topics: Adult; Bupropion; Humans; Nicotiana; Nicotinic Agonists; Smoking Cessation; Tobacco Use; Varenicline | 2022 |
Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis.
Topics: Benzazepines; Bupropion; Humans; Network Meta-Analysis; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Vaping-Cessation Interventions in Former Smokers.
Topics: Adult; Bupropion; Humans; Nicotinic Agonists; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Vaping; Varenicline | 2023 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Antidepressants for smoking cessation.
Topics: Adolescent; Adult; Antidepressive Agents; Bupropion; Child; Humans; Nicotinic Agonists; Nortriptyline; Smoking Cessation; Varenicline; Young Adult | 2023 |
Interventions for waterpipe smoking cessation.
Topics: Adolescent; Bupropion; Female; Humans; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Water Pipe Smoking | 2023 |
Efficacy and safety of antidepressants for smoking cessation: A systematic review and network meta-analysis.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Humans; Network Meta-Analysis; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023.
Topics: Adolescent; Alcoholism; Bupropion; Female; Humans; Nicotinic Agonists; Pregnancy; Pulmonary Medicine; Smoking Cessation; Thoracic Surgery; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2023 |
Cytisine for smoking cessation: A systematic review and meta-analysis.
Topics: Adult; Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Varenicline | 2023 |
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.
Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Female; Humans; Network Meta-Analysis; Nicotine; Nortriptyline; Pregnancy; Smoking Cessation; Varenicline | 2023 |
49 trial(s) available for bupropion and varenicline
| Article | Year |
|---|---|
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
Topics: Absenteeism; Benzazepines; Bupropion; Cost Savings; Cost-Benefit Analysis; Decision Trees; Employer Health Costs; Health Benefit Plans, Employee; Humans; Maintenance; Nicotinic Agonists; Program Evaluation; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Time Factors; Varenicline | 2007 |
Varenicline and bupropion sustained-release combination therapy for smoking cessation.
Topics: Adult; Aged; Benzazepines; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Varenicline; Young Adult | 2009 |
Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Humans; Male; Medication Adherence; Middle Aged; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2010 |
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Topics: Adolescent; Adult; Aged; Benzazepines; Breath Tests; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotinic Agonists; Placebos; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
Changes in health-related quality of life with smoking cessation treatment.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Health Status; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quality of Life; Quinoxalines; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Male; Midwestern United States; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline; Young Adult | 2011 |
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
Topics: Benzazepines; Bupropion; Counseling; Cultural Characteristics; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Indians, North American; Kansas; Nicotinic Agonists; Oklahoma; Patient Education as Topic; Quinoxalines; Research Design; Self-Help Groups; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.
Topics: Adolescent; Benzazepines; Bupropion; Double-Blind Method; Female; Humans; Male; Nausea; Pilot Projects; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2012 |
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
Topics: Adult; Benzazepines; Bupropion; Cognition; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Quinoxalines; Reaction Time; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2012 |
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
Topics: Adult; Aged; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacogenetics; Quinoxalines; Research Design; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Varenicline | 2013 |
Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzazepines; Bupropion; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking; Varenicline | 2013 |
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
Adapting smoking cessation treatment according to initial response to precessation nicotine patch.
Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Synergism; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Premedication; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
A multicentre randomized trial of combined individual and telephone counselling for smoking cessation.
Topics: Adult; Benzazepines; Bupropion; Combined Modality Therapy; Directive Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Smoking Cessation; Smoking Prevention; Spain; Telephone; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
Topics: Adult; Benzazepines; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).
Topics: Benzazepines; Bupropion; Canada; Female; Health Services Accessibility; Humans; Insurance, Health; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.
Topics: Adult; Aged; Benzazepines; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Odds Ratio; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; Varenicline | 2014 |
Depressive symptoms among patients receiving varenicline and bupropion for smoking cessation.
Topics: Adult; Bupropion; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
Topics: Bupropion; Combined Modality Therapy; Counseling; Cytochrome P-450 CYP2B6; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2015 |
An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS: Results of a Pilot Trial.
Topics: Adult; Algorithms; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; HIV Infections; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Empowering smokers with a web-assisted tobacco intervention to use prescription smoking cessation medications: a feasibility trial.
Topics: Adult; Bupropion; Female; Humans; Internet; Male; Middle Aged; Motivation; Office Visits; Ontario; Postal Service; Power, Psychological; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Aged; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2016 |
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupropion; Cohort Studies; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Smoking Cessation; Varenicline; Young Adult | 2016 |
Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Bayes Theorem; Bupropion; Follow-Up Studies; Humans; Middle Aged; Nicotinic Agonists; Reward; Smoking Cessation; Tobacco Smoking; Treatment Outcome; Varenicline | 2017 |
Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Male; Nicotinic Agonists; Smokers; Smoking; Smoking Cessation; Varenicline | 2017 |
Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.
Topics: Adult; Brain; Bupropion; Cigarette Smoking; Double-Blind Method; Emotions; Female; Humans; Male; Middle Aged; Photic Stimulation; Smokers; Smoking Cessation; Smoking Cessation Agents; Treatment Outcome; Varenicline | 2019 |
Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study.
Topics: Adult; Blinking; Bupropion; Delayed-Action Preparations; Emotions; Facial Muscles; Female; Humans; Male; Middle Aged; Reflex, Startle; Smoking; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2018 |
Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES.
Topics: Adult; Age Factors; Anxiety Disorders; Bupropion; Double-Blind Method; Ethnicity; Female; Humans; International Cooperation; Male; Middle Aged; Mood Disorders; Prognosis; Psychotic Disorders; Psychotropic Drugs; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Treatment Outcome; United States; Varenicline | 2018 |
Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
Topics: Bupropion; Cardiovascular Diseases; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Risk Factors; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2018 |
Mediators of the effect of nicotine pre-treatment on quitting smoking.
Topics: Adult; Behavior Therapy; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Premedication; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2018 |
Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
Topics: Adult; Bupropion; Cohort Studies; Double-Blind Method; Female; Humans; Internationality; Male; Mental Disorders; Middle Aged; Predictive Value of Tests; Prospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2019 |
Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Chromosomes, Human, Pair 15; Female; Gastrointestinal Diseases; Genetic Variation; Humans; Male; Middle Aged; Multigene Family; Nerve Tissue Proteins; Predictive Value of Tests; Receptors, Nicotinic; Smoking Cessation; Smoking Cessation Agents; Tobacco Use; Varenicline; Young Adult | 2020 |
Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.
Topics: Bipolar Disorder; Bupropion; Counseling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Random Allocation; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2019 |
Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial.
Topics: Aged; Bupropion; Cotinine; Counseling; Decision Support Techniques; Female; Humans; Male; Middle Aged; Motivational Interviewing; Neoplasms; Patient Satisfaction; Patient Selection; Saliva; Smoking; Smoking Cessation; Smoking Cessation Agents; Telephone; Temperance; Tobacco Use Cessation Devices; Varenicline | 2020 |
Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES.
Topics: Bupropion; Humans; Nicotinic Agonists; Schizophrenia; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
Topics: Black People; Bupropion; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Race Factors; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline; White People | 2021 |
Psychiatric Comorbidity and Multimorbidity in the EAGLES Trial: Descriptive Correlates and Associations With Neuropsychiatric Adverse Events, Treatment Adherence, and Smoking Cessation.
Topics: Bupropion; Humans; Male; Multimorbidity; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Adherence and Compliance; Varenicline | 2021 |
Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors.
Topics: Bayes Theorem; Benzazepines; Bupropion; Double-Blind Method; Humans; Nicotinic Agonists; Quinoxalines; Tobacco Use Cessation Devices; Varenicline | 2021 |
Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
Topics: Adult; Bupropion; Drug Tapering; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2021 |
Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: A pragmatic randomized controlled trial (MATCH study).
Topics: Benzazepines; Bupropion; Humans; Internet; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2022 |
The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
Topics: Bupropion; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Polyesters; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2022 |
E-cigarettes to Augment Stop Smoking In-person Support and Treatment With Varenicline (E-ASSIST): A Pragmatic Randomized Controlled Trial.
Topics: Adult; Bupropion; COVID-19; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Smoking; Varenicline | 2023 |
Effectiveness of Bupropion and Varenicline for Smokers With Baseline Depressive Symptoms.
Topics: Bupropion; Depression; Humans; Nicotinic Agonists; Smokers; Varenicline | 2023 |
Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial.
Topics: Adult; Bupropion; Ethnicity; Female; Humans; Male; Middle Aged; Minority Groups; Nicotine; Smoking; Smoking Cessation; Varenicline | 2023 |
Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
Topics: Bupropion; COVID-19; Female; Humans; Male; Middle Aged; Nicotine; Pandemics; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
195 other study(ies) available for bupropion and varenicline
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
[Medication for ending tobacco dependency. Current state].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline | 2005 |
Varenicline for smoking cessation: definite promise, but no panacea.
Topics: Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2006 |
[The path from cigarettes--with support it works better].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
[Tobacco use prevention and cessation in the dental practice].
Topics: Behavior Therapy; Benzazepines; Bupropion; Dentist-Patient Relations; Health Plan Implementation; Humans; Interview, Psychological; Mouth Neoplasms; Nicotinic Agonists; Obesity; Periodontitis; Professional Role; Quinoxalines; Self Efficacy; Surveys and Questionnaires; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline; Weight Gain | 2007 |
[Drug of the month. Varenicline (Champix)].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Treatment Outcome; Varenicline | 2007 |
[Giving up smoking is crucial for COPD patients].
Topics: Benzazepines; Bupropion; Family Practice; Humans; Patient Care Team; Patient Education as Topic; Physician-Patient Relations; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Secondary Prevention; Smoking Cessation; Varenicline | 2007 |
Smoking cessation: tactics that make a big difference.
Topics: Adult; Benzazepines; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; Nortriptyline; Patient Education as Topic; Quinoxalines; Smoking Cessation; Social Support; Varenicline | 2007 |
A new medication for the worst addiction.
Topics: Benzazepines; Bupropion; Drug Administration Schedule; Follow-Up Studies; Humans; Multicenter Studies as Topic; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
A second varenicline trial.
Topics: Benzazepines; Bupropion; Delayed-Action Preparations; Humans; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2007 |
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Theoretical; Netherlands; Nicotine; Nortriptyline; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
The truth about smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cost of Illness; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Econometric; Morbidity; Quality-Adjusted Life Years; Quinoxalines; Smoking Cessation; Sweden; Value of Life; Varenicline | 2008 |
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Genotype; Humans; Pharmacogenetics; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline | 2008 |
Drug addiction: a critical problem calling for novel solutions.
Topics: Benzazepines; Buprenorphine; Bupropion; Chronic Disease; Financing, Government; Genetic Testing; Harm Reduction; Humans; Marijuana Smoking; Naltrexone; Narcotic Antagonists; Prevalence; Privacy; Quinoxalines; Receptors, Nicotinic; Recurrence; Risk-Taking; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Substance-Related Disorders; Varenicline | 2008 |
Stat bite: Medicaid coverage of tobacco-dependence treatments.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Oral; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Insurance Coverage; Male; Medicaid; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Tobacco Use Disorder; United States; Varenicline | 2008 |
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Costs and Cost Analysis; Drug Costs; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2008 |
The place of varenicline in smoking cessation treatment.
Topics: Benzazepines; Bupropion; Cholinergic Agents; Clinical Trials, Phase III as Topic; Dopamine Uptake Inhibitors; Drug Costs; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
Smoking cessation: the psychiatrist's role.
Topics: Antimanic Agents; Benzazepines; Bipolar Disorder; Bupropion; Humans; Lithium Carbonate; Psychiatry; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.
Topics: Algorithms; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Consensus; Decision Support Techniques; Delphi Technique; Humans; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area | 2009 |
Smoking cessation: new ways to quit.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Behavior, Addictive; Benzazepines; Bupropion; Humans; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
A 51-year-old woman with bipolar disorder who wants to quit smoking.
Topics: Benzazepines; Bipolar Disorder; Bupropion; Counseling; Female; Humans; Middle Aged; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
[Specific program for smoking cessation: thus your patients become nonsmokers].
Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
Topics: Administration, Cutaneous; Adult; Benzazepines; Bupropion; Cohort Studies; Community Health Services; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Participation; Probability; Program Evaluation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United Kingdom; Varenicline; Young Adult | 2009 |
[Varenicline - pharmacological therapy of tobacco dependence].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Clinical Trials as Topic; Contraindications; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Pregnancy; Prospective Studies; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline | 2009 |
A reader responds to "Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months".
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Two recent updates for psychiatric conditions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atomoxetine Hydrochloride; Benzazepines; Bupropion; Chemical and Drug Induced Liver Injury; Congresses as Topic; Drug Labeling; Humans; Middle Aged; Product Surveillance, Postmarketing; Propylamines; Quinoxalines; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline | 2009 |
Treatment of comorbid tobacco use in people with serious mental illness.
Topics: Adult; Benzazepines; Bupropion; Comorbidity; Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Schizophrenia, Paranoid; Smoking; Smoking Cessation; Varenicline | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Cost-effectiveness of varenicline for smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Safety of smoking cessation drugs.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy.
Topics: Adult; Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; Directive Counseling; Female; Humans; Italy; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Quinoxalines; Retrospective Studies; Smoking Cessation; Treatment Outcome; Varenicline | 2009 |
Varenicline gets stronger warnings about psychiatric problems, vehicle crashes.
Topics: Accidents, Traffic; Benzazepines; Bupropion; Drug Labeling; Humans; Neurotransmitter Agents; Quinoxalines; Receptors, Nicotinic; Risk; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline | 2009 |
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Belgium; Benzazepines; Bupropion; Computer Simulation; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2009 |
Smoking cessation: how to advise the patient.
Topics: Ambulatory Care; Behavior Therapy; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Family Practice; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Suicide; Varenicline; Young Adult | 2009 |
Smoking cessation agents and suicide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Quinoxalines; Self-Injurious Behavior; Smoking Cessation; Suicide; Varenicline; Young Adult | 2009 |
[Drug treatment of tobacco dependence].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Costs and Cost Analysis; Databases, Factual; Dopamine Uptake Inhibitors; Female; Finland; Humans; Male; Markov Chains; Middle Aged; Models, Theoretical; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Integrating smoking cessation into HIV care.
Topics: Anti-HIV Agents; Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Government Programs; HIV Infections; Humans; Nicotinic Agonists; Oregon; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2010 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline | 2010 |
[The management of patients with nicotine dependence - the role of the general practitioners].
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Disease Management; Dopamine Uptake Inhibitors; Family Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Switzerland; Tobacco Use Disorder; Varenicline | 2010 |
[Medical therapy for smoking cessation].
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Antidepressive Agents; Benzazepines; Bupropion; Chewing Gum; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
Topics: Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult | 2011 |
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.
Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Bupropion; Canada; Cohort Studies; Data Collection; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nonprescription Drugs; Prescription Drugs; Prevalence; Quinoxalines; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2011 |
Pharmacotherapy for smoking.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2011 |
Integrating results from smoking cessation drug research and development into clinical occupational health practice.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Occupational Health Nursing; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzazepines; Bupropion; DNA, Complementary; Dopamine Uptake Inhibitors; Electrophysiological Phenomena; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridinium Compounds; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus | 2011 |
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Quinoxalines; Retrospective Studies; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2011 |
Prescribing of smoking cessation medication in England since the introduction of varenicline.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Time Factors; Varenicline | 2011 |
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nasal Sprays; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; Treatment Outcome; Varenicline | 2011 |
Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
Topics: Adult; Benzazepines; Bupropion; Drug Utilization; England; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2011 |
Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; England; Epidemiologic Methods; Health Care Costs; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Wales | 2011 |
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Female; Humans; Male; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Time Factors; Varenicline; Young Adult | 2011 |
Smoking cessation pharmacotherapy: a concise overview.
Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2011 |
Assessing preferences for improved smoking cessation medications: a discrete choice experiment.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Models, Econometric; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Switzerland; Varenicline; Young Adult | 2012 |
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Policy; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Acceptance of Health Care; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Cessation Devices; Varenicline; Vietnam; Young Adult | 2012 |
[Smoking cessation--assistance for the general practitioner].
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2011 |
Suicidal behavior and depression in smoking cessation treatments.
Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline | 2011 |
Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Health Behavior; Humans; Longitudinal Studies; Male; Motivation; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Real world evaluation of three models of NHS smoking cessation service in England.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Community Health Services; Counseling; England; Female; Humans; Male; Nicotinic Agonists; Pregnancy; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
Prescribing of nicotine replacement therapy to cardiovascular disease patients in England.
Topics: Adult; Benzazepines; Bupropion; Coronary Disease; Drug Prescriptions; England; General Practice; Humans; Nicotinic Agonists; Prescription Drugs; Quinoxalines; Regression Analysis; Smoking Cessation; Smoking Prevention; Stroke; Tobacco Use Cessation Devices; Varenicline | 2012 |
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Topics: Benzazepines; Bupropion; Cardiovascular Diseases; Central America; Cost-Benefit Analysis; Dominican Republic; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Coronary Disease; Costs and Cost Analysis; Dopamine Uptake Inhibitors; Health Expenditures; Humans; Lung Neoplasms; Middle Aged; Nicaragua; Nicotinic Agonists; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Stroke; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2012 |
An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Benzazepines; Bupropion; Data Collection; Educational Status; Female; Humans; Internet; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
Promoting smoking cessation.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Complementary Therapies; Family Practice; Female; Health Promotion; Humans; Male; Motivation; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline | 2012 |
Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.
Topics: Adult; Aged; Benzazepines; Bupropion; Female; Hospitalization; Humans; Male; Mental Disorders; Middle Aged; Military Personnel; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline; Young Adult | 2013 |
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Topics: Benzazepines; Bupropion; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Drug Costs; Greece; Health Care Costs; Humans; Insurance, Health, Reimbursement; Markov Chains; Models, Economic; Monte Carlo Method; Prevalence; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2012 |
Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
Topics: Adolescent; Adult; Age Distribution; Aged; Australia; Benzazepines; Bupropion; Canada; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2013 |
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Electron Transport; Gene Expression; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mitochondria; Nicotine; Nicotinic Agonists; Oxidative Stress; Pancreatic Function Tests; Quinoxalines; Rats; Signal Transduction; Smoking; Smoking Cessation; Varenicline | 2012 |
Alpha oscillations in response to affective and cigarette-related stimuli in smokers.
Topics: Adult; Attention; Benzazepines; Brain; Bupropion; Cues; Demography; Electroencephalography Phase Synchronization; Emotions; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Photic Stimulation; Quinoxalines; Recurrence; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Products; Varenicline | 2013 |
Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
Topics: Benzazepines; Bupropion; Chromosomes, Human, Pair 15; Genetic Loci; Genome-Wide Association Study; Humans; Multigene Family; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Receptors, Nicotinic; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Strategies to help a smoker who is struggling to quit.
Topics: Behavior Therapy; Benzazepines; Bupropion; Chronic Disease; Counseling; Disease Management; Dopamine Uptake Inhibitors; Hotlines; Humans; Male; Middle Aged; Nicotinic Agonists; Physician-Patient Relations; Physician's Role; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Brazil; Bupropion; Demography; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2013 |
[Methods and results of smoking cessation in cancer smoker's].
Topics: Benzazepines; Bupropion; Humans; Neoplasms; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Smoke Pollution; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2012 |
Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.
Topics: Acute Coronary Syndrome; Adult; Age Distribution; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confidence Intervals; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Quinoxalines; Retrospective Studies; Risk Assessment; Sex Distribution; Smoking Cessation; Stroke; Survival Analysis; Varenicline | 2012 |
Tracking dental patient tobacco use and intervention in the academic clinical setting.
Topics: Age of Onset; Benzazepines; Bupropion; Counseling; Dental Records; Dopamine Uptake Inhibitors; Electronic Health Records; Female; Follow-Up Studies; Humans; Male; Medical History Taking; Nicotinic Agonists; Patient Education as Topic; Quinoxalines; Referral and Consultation; Schools, Dental; Smoking; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Varenicline; West Virginia | 2012 |
Varenicline and bupropion: suicide.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Patient Safety; Prescription Drug Misuse; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Suicide; Varenicline | 2012 |
[Consensus report for the clinical care of smoking cessation in Spain. Comité Nacional para la Prevención del Tabaquismo].
Topics: Benzazepines; Bupropion; Counseling; Humans; Motivation; Nicotinic Agonists; Patient Compliance; Patient Education as Topic; Persuasive Communication; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Use of varenicline versus bupropion and risk of psychiatric adverse events.
Topics: Adult; Benzazepines; Bupropion; Denmark; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Proportional Hazards Models; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Treatment Outcome; Varenicline | 2013 |
Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
Topics: Adult; Benzazepines; Bupropion; Comparative Effectiveness Research; Dopamine Uptake Inhibitors; Drug Therapy, Combination; England; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program.
Topics: Adult; Aged; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Prescriptions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Risk Assessment; Risk Factors; Sentinel Surveillance; Smoking Cessation; Tobacco Use Disorder; United States; United States Food and Drug Administration; Varenicline | 2013 |
Treatment of smoking in smokers with chronic obstructive pulmonary disease. Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Motivation; Multicenter Studies as Topic; Program Evaluation; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Randomized Controlled Trials as Topic; Reward; Severity of Illness Index; Smoking; Smoking Cessation; Spain; Surveys and Questionnaires; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
Topics: Adult; Benzazepines; Bupropion; Clinical Trials as Topic; Computer Simulation; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Quality of Life; Quinoxalines; Recurrence; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
[Results of a multidisciplinary program to quit smoking].
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Care Team; Program Evaluation; Quinoxalines; Smoking; Smoking Cessation; Socioeconomic Factors; Treatment Outcome; Varenicline; Young Adult | 2013 |
Varenicline, smoking cessation, and neuropsychiatric adverse events.
Topics: Adult; Aggression; Akathisia, Drug-Induced; Benzazepines; Bupropion; Depression; Female; Humans; Male; Mental Disorders; Nausea; Observational Studies as Topic; Psychomotor Agitation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Suicidal Ideation; Suicide, Attempted; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2013 |
Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Depression; England; Female; Humans; Male; Middle Aged; Prospective Studies; Quinoxalines; Risk Assessment; Risk Factors; Self-Injurious Behavior; Smoking; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
Effect of allopurinol on smoking.
Topics: Acetylcholine; Allopurinol; Benzazepines; Brain Chemistry; Bupropion; Causality; Comorbidity; Diabetic Nephropathies; Humans; Hypoxanthine; Molecular Structure; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Structure-Activity Relationship; Varenicline; Xanthine Oxidase | 2013 |
Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bipolar Disorder; Bupropion; Clinical Trials as Topic; Follow-Up Studies; Humans; Motivational Interviewing; Nicotinic Agonists; Psychotherapy, Group; Quinoxalines; Schizophrenic Psychology; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
'Real-world' effectiveness of smoking cessation treatments: a population study.
Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2014 |
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
Tobacco quitline outcomes by service type.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Longitudinal Studies; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; South Dakota; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2014 |
General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Chronic Disease; Drug Therapy, Combination; Electronic Health Records; Female; General Practitioners; Humans; Male; Middle Aged; Nicotinic Agonists; Patient Selection; Practice Patterns, Physicians'; Quinoxalines; Research Design; Retrospective Studies; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United Kingdom; Varenicline; Young Adult | 2014 |
quit4u: the effectiveness of combining behavioural support, pharmacotherapy and financial incentives to support smoking cessation.
Topics: Adolescent; Adult; Bupropion; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Motivation; Psychotherapy, Group; Scotland; Smoking Cessation; Socioeconomic Factors; State Medicine; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2015 |
Tobacco smoking: options for helping smokers to quit.
Topics: Australia; Benzazepines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; General Practice; Harm Reduction; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
[Abstinence rates among varenicline are highest].
Topics: Benzazepines; Bupropion; Humans; Mental Disorders; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2014 |
Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
Topics: Aged; Aged, 80 and over; Benzazepines; Bupropion; Cardiovascular Diseases; Cohort Studies; Comorbidity; Female; Humans; Incidence; Male; Medicare; Nicotinic Agonists; Quinoxalines; Smoking Cessation; United States; Varenicline | 2014 |
Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cohort Studies; General Practice; Humans; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; United Kingdom; Varenicline | 2014 |
Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats.
Topics: Animals; Benzazepines; Bupropion; Cholinergic Agents; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Male; Naltrexone; Narcotic Antagonists; Nicotine; Quinoxalines; Rats; Rats, Long-Evans; Reinforcement, Psychology; Varenicline | 2014 |
Emotional disorders and smoking: relations to quit attempts and cessation strategies among treatment-seeking smokers.
Topics: Adult; Anxiety Disorders; Benzazepines; Bupropion; Cross-Sectional Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2015 |
Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Odds Ratio; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2015 |
Maintenance of tobacco cessation programmes in public hospitals in Catalonia, Spain.
Topics: Benzazepines; Bupropion; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Hospitalization; Hospitals, Public; Humans; Inpatients; Nicotinic Agonists; Personnel, Hospital; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Nationwide Smoking Cessation Treatment Support Program--Turkey project.
Topics: Adult; Bupropion; Female; Health Policy; Humans; Male; Middle Aged; Program Evaluation; Smoking Cessation; Tobacco Use Cessation Devices; Turkey; Varenicline | 2015 |
Providing medication therapy management for smoking cessation patients.
Topics: Bupropion; Humans; Medication Adherence; Medication Therapy Management; Nicotinic Agonists; Professional Role; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2015 |
Real-life effectiveness of smoking-cessation treatments in general practice clinics in Denmark. The Escape Smoke project.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Counseling; Denmark; Dopamine Uptake Inhibitors; Female; General Practice; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Young Adult | 2015 |
Bupropion-varenicline interactions and nicotine self-administration behavior in rats.
Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Drug Synergism; Female; Nicotine; Rats; Self Administration; Varenicline | 2015 |
Higher Adherence During Reimbursement of Pharmacological Smoking Cessation Treatments.
Topics: Adult; Bupropion; Counseling; Female; Humans; Insurance, Health, Reimbursement; Male; Medication Adherence; Middle Aged; Netherlands; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2016 |
Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report.
Topics: Bupropion; Counseling; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers.
Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; United States; Varenicline; Young Adult | 2015 |
Homeless Clients Benefit From Smoking Cessation Treatment Delivered by a Homeless Persons' Program.
Topics: Bupropion; Community Health Nursing; Delivery of Health Care, Integrated; Female; Health Promotion; Humans; Ill-Housed Persons; Male; Middle Aged; Patient Acceptance of Health Care; Smoking Cessation; Surveys and Questionnaires; Telemedicine; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; Victoria | 2015 |
Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.
Topics: Bupropion; Counseling; Humans; Insurance Carriers; Insurance Coverage; Logistic Models; Medicaid; Multivariate Analysis; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2015 |
Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.
Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Recurrence; Smokers; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult | 2016 |
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.
Topics: Adult; Bupropion; Cardiovascular Diseases; Depression; Dopamine Uptake Inhibitors; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2015 |
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement.
Topics: Adult; Behavior Therapy; Biomedical Research; Bupropion; Cost of Illness; Counseling; Electronic Nicotine Delivery Systems; Female; Humans; Nicotinic Agonists; Pregnancy; Risk Assessment; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline | 2015 |
Summaries for Patients. Behavioral and Pharmacologic Treatments to Help Adults Quit Smoking: U.S. Preventive Services Task Force Recommendation Statement.
Topics: Adult; Behavior Therapy; Bupropion; Counseling; Electronic Nicotine Delivery Systems; Female; Humans; Nicotinic Agonists; Pregnancy; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; United States; Varenicline | 2015 |
Smoking cessation and the effect of nicotine dependence on relapse rate in Izmir, Turkey.
Topics: Adult; Behavior Therapy; Benzazepines; Bupropion; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Prospective Studies; Quinoxalines; Recurrence; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Turkey; Varenicline | 2015 |
Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Female; Health Care Costs; Health Expenditures; Humans; Male; Markov Chains; Middle Aged; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Varenicline | 2015 |
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers.
Topics: Adolescent; Adult; Aged; Bupropion; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 2; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Nicotinic Agonists; Obesity; Proportional Hazards Models; Retrospective Studies; Risk; Smoking; Smoking Cessation; Varenicline; Young Adult | 2015 |
Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Admission; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; United States; United States Department of Veterans Affairs; Varenicline | 2016 |
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
Topics: Adult; Aged; Blood Pressure; Brazil; Bupropion; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Diastole; Dopamine Uptake Inhibitors; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Systole; Tobacco Use Cessation Devices; Varenicline | 2016 |
[Varenicline in nicotine replacement therapy: Does it really increase the risk of cardiovascular and neuropsychiatric events?].
Topics: Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Varenicline | 2016 |
Neighbourhood Deprivation and Outcomes of Stop Smoking Support--An Observational Study.
Topics: Adult; Bupropion; Female; Humans; Logistic Models; London; Male; Middle Aged; Nicotinic Agonists; Patient Compliance; Poverty; Residence Characteristics; Smoking; Smoking Cessation; Smoking Prevention; Social Class; Tobacco Use Cessation Devices; Varenicline | 2016 |
Factors affecting dropout in the smoking cessation outpatient clinic.
Topics: Adult; Age Factors; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Educational Status; Female; Humans; Male; Middle Aged; Motivation; Nicotinic Agonists; Patient Dropouts; Retrospective Studies; Sex Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2016 |
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.
Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Conditioning, Operant; Discrimination Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Macaca mulatta; Male; Methamphetamine; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Risperidone; Time Factors; Varenicline | 2016 |
Drugs for smoking cessation.
Topics: Bupropion; Contraindications; Dopamine Uptake Inhibitors; Drug Monitoring; Female; Humans; Middle Aged; Nicotinic Agonists; Practice Guidelines as Topic; Pregnancy; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2016 |
Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation.
Topics: Adult; Bupropion; Female; Humans; Male; Middle Aged; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Weight Gain | 2016 |
Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany.
Topics: Adult; Aged; Bupropion; Cost-Benefit Analysis; Cross-Sectional Studies; Dopamine Uptake Inhibitors; Female; Financing, Personal; Germany; Humans; Logistic Models; Male; Middle Aged; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2016 |
Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012.
Topics: Aged; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Medicare; Middle Aged; Nicotinic Agonists; Prescription Drugs; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline | 2016 |
Safety of smoking cessation drugs for mentally ill patients.
Topics: Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotinic Agonists; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2016 |
Effects of aging on the effectiveness of smoking cessation medication.
Topics: Adult; Age Factors; Aged; Brazil; Bupropion; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Precision Medicine; Smoking Cessation; Treatment Outcome; Varenicline | 2016 |
Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: Recommendation Statement.
Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Counseling; Electronic Nicotine Delivery Systems; Female; Health Plan Implementation; Humans; Male; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking Prevention; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline | 2016 |
The use of varenicline to treat nicotine dependence among patients with cancer.
Topics: Adult; Benzazepines; Bupropion; Counseling; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Varenicline | 2016 |
A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.
Topics: Adult; Algorithms; Antidepressive Agents, Second-Generation; Black or African American; Bupropion; Counseling; Female; HIV Infections; Humans; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline; White People | 2017 |
Guidelines for the Treatment of Smoking in Hospitalized Patients.
Topics: Bupropion; Clinical Trials as Topic; Comorbidity; Counseling; Evidence-Based Medicine; Humans; Inpatients; Meta-Analysis as Topic; Motivation; Practice Guidelines as Topic; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Varenicline | 2017 |
The Adverse Effects and Treatment Results of Smoking Cessation Pharmacotherapy During Fasting/Non-Fasting State.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Fasting; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2017 |
Medicaid Coverage of Smoking Cessation Counseling and Medication Is Underutilized for Pregnant Women.
Topics: Adult; Bupropion; Counseling; Databases, Factual; Dopamine Uptake Inhibitors; Female; Humans; Insurance Coverage; Kansas; Medicaid; Nicotinic Agonists; Poverty; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United States; Varenicline; Young Adult | 2017 |
Cardiovascular and neuropsychiatric risks of varenicline and bupropion in smokers with chronic obstructive pulmonary disease.
Topics: Adult; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; England; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Propensity Score; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2017 |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
Topics: Biomarkers; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Counseling; Evidence-Based Medicine; Humans; Motivation; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline | 2017 |
Treatment With Bupropion and Varenicline for Smoking Cessation and the Risk of Acute Cardiovascular Events and Injuries: a Swedish Case-Crossover Study.
Topics: Accidental Falls; Accidents, Traffic; Adult; Bupropion; Cardiovascular Diseases; Cross-Over Studies; Humans; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome; Suicide, Attempted; Sweden; Tobacco Use Disorder; Varenicline; Wounds and Injuries | 2018 |
Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.
Topics: Adolescent; Adult; Aged; Bupropion; Cross-Sectional Studies; Drug Labeling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration; Varenicline; Young Adult | 2017 |
[Design and user-testing of a decision aid comparing medications for smoking cessation].
Topics: Bupropion; Decision Support Techniques; Humans; Patient Preference; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2017 |
Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice.
Topics: Age Factors; Aged; Bupropion; Comorbidity; Female; Humans; Lung Diseases; Male; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Peripheral Arterial Disease; Secondary Prevention; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2017 |
Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
Topics: Bupropion; Cost-Benefit Analysis; Depressive Disorder, Major; Female; Health Care Costs; Humans; Male; Markov Chains; Smoking; Smoking Cessation; Spain; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
Use of prescribed smoking cessation pharmacotherapy following release from prison: a prospective data linkage study.
Topics: Adult; Age Factors; Australia; Bupropion; Female; Humans; Information Storage and Retrieval; Male; Patient Acceptance of Health Care; Prisoners; Prospective Studies; Risk Factors; Smoking; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2018 |
In smokers with COPD, neither varenicline nor bupropion was linked to increased CV or neuropsychiatric risk vs NRT.
Topics: Benzazepines; Bupropion; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smokers; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2017 |
Evaluation of smoking cessation intervention in patients with chronic diseases in smoking cessation clinics.
Topics: Adult; Bupropion; Chronic Disease; Combined Modality Therapy; Counseling; Follow-Up Studies; Humans; Intention to Treat Analysis; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2017 |
Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
Topics: 5' Untranslated Regions; Adult; Aged; Bupropion; Carbon Monoxide; Exhalation; Female; Humans; Male; Middle Aged; Nerve Tissue Proteins; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2017 |
[Clinical Practice Guidelines for Smoking Cessation].
Topics: Bupropion; Chile; Evidence-Based Medicine; Humans; Nicotine; Smoking Cessation; Varenicline | 2017 |
Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study.
Topics: Adult; Age Factors; Aged; Bupropion; Denmark; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Regression Analysis; Sex Factors; Smoking; Smoking Cessation; Smoking Cessation Agents; Socioeconomic Factors; Varenicline | 2018 |
Real-World Effectiveness of Pharmaceutical Smoking Cessation Aids: Time-Varying Effects.
Topics: Adolescent; Adult; Aged; Benzazepines; Bupropion; Female; Health Behavior; Humans; Male; Middle Aged; Nicotinic Agonists; Ontario; Pharmaceutic Aids; Smokers; Smoking; Smoking Cessation; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2020 |
Cost-utility analysis of smoking cessation to prevent operative complications following elective abdominal colon surgery.
Topics: Bupropion; Colectomy; Cost-Benefit Analysis; Decision Trees; Elective Surgical Procedures; Health Care Costs; Humans; Postoperative Complications; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2018 |
Which Types of Tobacco Treatment Interventions Work for People with Schizophrenia? Provider and Mental Health Consumer Perspectives.
Topics: Adult; Attitude of Health Personnel; Behavior Therapy; Bupropion; Counseling; Female; Health Education; Health Promotion; Health Services Needs and Demand; Humans; Interview, Psychological; Male; Middle Aged; Patient Acceptance of Health Care; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Social Support; Treatment Outcome; United States; Varenicline; Young Adult | 2019 |
Individual differences in responding to bupropion or varenicline in a preclinical model of nicotine self-administration vary according to individual demand for nicotine.
Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Extinction, Psychological; Individuality; Male; Nicotine; Rats; Reinforcement Schedule; Self Administration; Sucrose; Varenicline | 2019 |
Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
Topics: Behavior Therapy; Bupropion; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United States; Varenicline | 2019 |
Cost-effectiveness of real-world administration of tobacco pharmacotherapy in the United States Veterans Health Administration.
Topics: Adult; Aged; Bupropion; Cohort Studies; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Retrospective Studies; Smoking Cessation Agents; Tobacco Use; Tobacco Use Cessation; Tobacco Use Cessation Devices; United States; United States Department of Veterans Affairs; Varenicline; Veterans Health | 2019 |
Moderators of real-world effectiveness of smoking cessation aids: a population study.
Topics: Adolescent; Adult; Age Factors; Aged; Bupropion; Counseling; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; England; Female; Humans; Hypnosis; Internet; Male; Middle Aged; Nonprescription Drugs; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Social Class; Surveys and Questionnaires; Telephone; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult | 2019 |
Predictors of long-term abstinence rate by income level in the Korean smoking cessation programme.
Topics: Adult; Bupropion; Female; Humans; Income; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Republic of Korea; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2019 |
Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats.
Topics: Alcohol-Related Disorders; Animals; Bupropion; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Male; Nucleus Accumbens; Rats; Rats, Wistar; Smoking Cessation Agents; Varenicline | 2020 |
Estimation of high-dimensional propensity scores with multiple exposure levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bupropion; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Pharmacoepidemiology; Propensity Score; Proportional Hazards Models; Retrospective Studies; Smoking Cessation; United Kingdom; Varenicline; Young Adult | 2020 |
Health-care providers' concern regarding smoking cessation pharmacotherapies during pregnancy: Calls to a teratology information service.
Topics: Australia; Behavior Therapy; Bupropion; Call Centers; Female; Health Personnel; Humans; Information Services; Nicotine; Pregnancy; Smoking; Smoking Cessation; Teratology; Tobacco Use Cessation Devices; Varenicline | 2020 |
Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019.
Topics: Africa, Northern; Bupropion; Health Services Accessibility; Humans; Middle East; Primary Health Care; Smoking Cessation; Smoking Cessation Agents; Varenicline | 2020 |
Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Bupropion; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline; Young Adult | 2020 |
Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; Bupropion; Conditioning, Psychological; Economics, Behavioral; Extinction, Psychological; Female; Individuality; Nicotine; Nicotinic Agonists; Rats; Self Administration; Smoking Cessation Agents; Varenicline; Yohimbine | 2020 |
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
Topics: Adult; Bupropion; Crohn Disease; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Pilot Projects; Prevalence; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2020 |
Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Bupropion; Female; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacovigilance; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration; Varenicline; Young Adult | 2020 |
[Influencing factors on smoking cessation among outpatients from the National Central Subsidy Smoking Cessation Clinic Project, in 2015-2018].
Topics: Bupropion; China; Follow-Up Studies; Humans; Outpatients; Program Evaluation; Smoking Cessation; Surveys and Questionnaires; Varenicline | 2020 |
The Persistent Challenge of Developing Addiction Pharmacotherapies.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Drug Therapy; Humans; Naltrexone; Narcotic Antagonists; Nicotinic Agonists; Smoking Cessation Agents; Substance-Related Disorders; Varenicline | 2021 |
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Female; Humans; Male; Middle Aged; Practice Guidelines as Topic; Smoking Cessation Agents; Tobacco Use Disorder; United States; Varenicline | 2020 |
Essential tobacco dependence medicines in 137 countries.
Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2021 |
Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.
Topics: Adult; Aged; Benzazepines; Bupropion; Cross-Over Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Self-Injurious Behavior; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; United Kingdom; Varenicline | 2021 |
Commentary on Thomas et al.: Are simple solutions to complex problems possible?
Topics: Bupropion; Cross-Over Studies; Humans; Smoking Cessation; Tobacco Use Cessation Devices; United Kingdom; Varenicline | 2021 |
Neuropsychiatric safety of varenicline in the general and COPD population with and without psychiatric disorders: a retrospective cohort study in a real-world setting.
Topics: Benzazepines; Bupropion; Cohort Studies; Humans; Netherlands; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Retrospective Studies; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis.
Topics: Benzazepines; Bupropion; Humans; Quinoxalines; Smoking Cessation; Varenicline | 2022 |
Cost-effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world.
Topics: Adult; Bupropion; Cost-Benefit Analysis; Humans; Male; Retrospective Studies; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2022 |
Bupropion for smoking cessation in adolescents.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Humans; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2021 |
Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
Topics: Adult; Bupropion; Cardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; New South Wales; Retrospective Studies; Smoking; Smoking Cessation Agents; Varenicline | 2021 |
Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
Topics: Aged; Australia; Benzazepines; Bupropion; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
The 2022 Ferno Award Address: CrEATE, an Efficient Crossover Evaluation of Addiction Treatment Efficacy.
Topics: Benzazepines; Bupropion; Cross-Over Studies; Humans; Nicotinic Agonists; Smoking; Treatment Outcome; Varenicline | 2023 |
[Tobacco cessation treatment for people with schizophrenia].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Abstinence Rate, Adverse Events and Withdrawal Symptoms after Varenicline Use and Predicting Factors of Smoking Abstinence: A Multicentre Single-State Study in Malaysia.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Cohort Studies; Humans; Malaysia; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline | 2022 |
Cost-Effectiveness Analysis of Smoking Cessation Interventions With Behavioral Support: A Study Based on the Benefits of Smoking Cessation on Outcomes (BENESCO) Model.
Topics: Adult; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Humans; Male; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.
Topics: Bupropion; COVID-19; Humans; Interrupted Time Series Analysis; Nicotine; Nicotinic Agonists; Pandemics; Pharmaceutical Preparations; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Smoking Cessation Medication Prescribing for Smokers With and Without Mental Illness.
Topics: Bupropion; Humans; Nicotinic Agonists; Smokers; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Smoking Cessation Interventions.
Topics: Adolescent; Adult; Bupropion; Child; Early Detection of Cancer; Electronic Nicotine Delivery Systems; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2022 |
Varenicline serves as the training stimulus in the drug-discriminated goal-tracking task with rats: initial evaluation of potential neuropharmacological processes.
Topics: Animals; Benzazepines; Bupropion; Goals; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Smoking Cessation Agents; Varenicline | 2023 |
How do patients and staff in an opioid agonist treatment service view smoking cessation medications and e-cigarettes?
Topics: Analgesics, Opioid; Australia; Bupropion; Cross-Sectional Studies; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Smoking cessation and vaccination.
Topics: Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Tobacco Use Cessation Devices; Vaccination; Varenicline | 2023 |
The utility of the self-controlled study design for pharmacoepidemiological studies without an active comparator medication using a medical information database: An application to assess the risk of varenicline on cardiovascular outcomes.
Topics: Adult; Bupropion; Cohort Studies; Humans; Male; Proportional Hazards Models; Smoking Cessation; Varenicline | 2023 |
Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy.
Topics: Bayes Theorem; Bupropion; Humans; Smoking; Smoking Cessation; Varenicline | 2023 |
Behavioral therapy and pharmacotherapy: A case report on right approach for tobacco cessation.
Topics: Aged, 80 and over; Behavior Therapy; Bupropion; Humans; Male; Smoking Cessation; Tobacco Use Cessation; Varenicline | 2023 |
Initiation of Varenicline in People Hospitalized for Acute Coronary Syndrome Who Smoke.
Topics: Acute Coronary Syndrome; Benzazepines; Bupropion; Cognition; Humans; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2023 |